Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) — Boston, Massachusetts

Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) has participated in 1 clinical trials.

Therapeutic areas: Metastatic Melanoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3)?

Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) conducted?

Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) has 1 clinical trials on record. Their work covers Metastatic Melanoma.

Is Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) accredited by Crixeo Health?

Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.